Global Digital Biomarker Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Description

According to our (Global Info Research) latest study, the global Digital Biomarker market size was valued at US$ 622 million in 2024 and is forecast to a readjusted size of USD 37610 million by 2031 with a CAGR of 80.6% during review period.

Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.

Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.

This report is a detailed and comprehensive analysis for global Digital Biomarker market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Digital Biomarker market size and forecasts, in consumption value ($ Million), 2020-2031
Global Digital Biomarker market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Digital Biomarker market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Digital Biomarker market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Digital Biomarker
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Digital Biomarker market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Apple, Sanofi, GlaxoSmithKline, Bayer, Merck, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Digital Biomarker market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Passive Digital Biomarker
    Active Digital Biomarker

Market segment by Application
    Clinical Disease
    Daily Health

Market segment by players, this report covers
    Philips
    Johnson & Johnson
    Pfizer
    GE Healthcare
    Novartis
    Apple
    Sanofi
    GlaxoSmithKline
    Bayer
    Merck
    Abbott Laboratories
    Asahi Kasei
    Biogen
    Koneksa Health
    Roche
    Huma Therapeutics

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Digital Biomarker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Digital Biomarker, with revenue, gross margin, and global market share of Digital Biomarker from 2020 to 2025.
Chapter 3, the Digital Biomarker competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Digital Biomarker market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Digital Biomarker.
Chapter 13, to describe Digital Biomarker research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Digital Biomarker by Type
        1.3.1 Overview: Global Digital Biomarker Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Digital Biomarker Consumption Value Market Share by Type in 2024
        1.3.3 Passive Digital Biomarker
        1.3.4 Active Digital Biomarker
    1.4 Global Digital Biomarker Market by Application
        1.4.1 Overview: Global Digital Biomarker Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Clinical Disease
        1.4.3 Daily Health
    1.5 Global Digital Biomarker Market Size & Forecast
    1.6 Global Digital Biomarker Market Size and Forecast by Region
        1.6.1 Global Digital Biomarker Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Digital Biomarker Market Size by Region, (2020-2031)
        1.6.3 North America Digital Biomarker Market Size and Prospect (2020-2031)
        1.6.4 Europe Digital Biomarker Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Digital Biomarker Market Size and Prospect (2020-2031)
        1.6.6 South America Digital Biomarker Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Digital Biomarker Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 Philips
        2.1.1 Philips Details
        2.1.2 Philips Major Business
        2.1.3 Philips Digital Biomarker Product and Solutions
        2.1.4 Philips Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Philips Recent Developments and Future Plans
    2.2 Johnson & Johnson
        2.2.1 Johnson & Johnson Details
        2.2.2 Johnson & Johnson Major Business
        2.2.3 Johnson & Johnson Digital Biomarker Product and Solutions
        2.2.4 Johnson & Johnson Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Johnson & Johnson Recent Developments and Future Plans
    2.3 Pfizer
        2.3.1 Pfizer Details
        2.3.2 Pfizer Major Business
        2.3.3 Pfizer Digital Biomarker Product and Solutions
        2.3.4 Pfizer Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Pfizer Recent Developments and Future Plans
    2.4 GE Healthcare
        2.4.1 GE Healthcare Details
        2.4.2 GE Healthcare Major Business
        2.4.3 GE Healthcare Digital Biomarker Product and Solutions
        2.4.4 GE Healthcare Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 GE Healthcare Recent Developments and Future Plans
    2.5 Novartis
        2.5.1 Novartis Details
        2.5.2 Novartis Major Business
        2.5.3 Novartis Digital Biomarker Product and Solutions
        2.5.4 Novartis Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Novartis Recent Developments and Future Plans
    2.6 Apple
        2.6.1 Apple Details
        2.6.2 Apple Major Business
        2.6.3 Apple Digital Biomarker Product and Solutions
        2.6.4 Apple Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 Apple Recent Developments and Future Plans
    2.7 Sanofi
        2.7.1 Sanofi Details
        2.7.2 Sanofi Major Business
        2.7.3 Sanofi Digital Biomarker Product and Solutions
        2.7.4 Sanofi Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 Sanofi Recent Developments and Future Plans
    2.8 GlaxoSmithKline
        2.8.1 GlaxoSmithKline Details
        2.8.2 GlaxoSmithKline Major Business
        2.8.3 GlaxoSmithKline Digital Biomarker Product and Solutions
        2.8.4 GlaxoSmithKline Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 GlaxoSmithKline Recent Developments and Future Plans
    2.9 Bayer
        2.9.1 Bayer Details
        2.9.2 Bayer Major Business
        2.9.3 Bayer Digital Biomarker Product and Solutions
        2.9.4 Bayer Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Bayer Recent Developments and Future Plans
    2.10 Merck
        2.10.1 Merck Details
        2.10.2 Merck Major Business
        2.10.3 Merck Digital Biomarker Product and Solutions
        2.10.4 Merck Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 Merck Recent Developments and Future Plans
    2.11 Abbott Laboratories
        2.11.1 Abbott Laboratories Details
        2.11.2 Abbott Laboratories Major Business
        2.11.3 Abbott Laboratories Digital Biomarker Product and Solutions
        2.11.4 Abbott Laboratories Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 Abbott Laboratories Recent Developments and Future Plans
    2.12 Asahi Kasei
        2.12.1 Asahi Kasei Details
        2.12.2 Asahi Kasei Major Business
        2.12.3 Asahi Kasei Digital Biomarker Product and Solutions
        2.12.4 Asahi Kasei Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.12.5 Asahi Kasei Recent Developments and Future Plans
    2.13 Biogen
        2.13.1 Biogen Details
        2.13.2 Biogen Major Business
        2.13.3 Biogen Digital Biomarker Product and Solutions
        2.13.4 Biogen Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.13.5 Biogen Recent Developments and Future Plans
    2.14 Koneksa Health
        2.14.1 Koneksa Health Details
        2.14.2 Koneksa Health Major Business
        2.14.3 Koneksa Health Digital Biomarker Product and Solutions
        2.14.4 Koneksa Health Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.14.5 Koneksa Health Recent Developments and Future Plans
    2.15 Roche
        2.15.1 Roche Details
        2.15.2 Roche Major Business
        2.15.3 Roche Digital Biomarker Product and Solutions
        2.15.4 Roche Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.15.5 Roche Recent Developments and Future Plans
    2.16 Huma Therapeutics
        2.16.1 Huma Therapeutics Details
        2.16.2 Huma Therapeutics Major Business
        2.16.3 Huma Therapeutics Digital Biomarker Product and Solutions
        2.16.4 Huma Therapeutics Digital Biomarker Revenue, Gross Margin and Market Share (2020-2025)
        2.16.5 Huma Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Digital Biomarker Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Digital Biomarker by Company Revenue
        3.2.2 Top 3 Digital Biomarker Players Market Share in 2024
        3.2.3 Top 6 Digital Biomarker Players Market Share in 2024
    3.3 Digital Biomarker Market: Overall Company Footprint Analysis
        3.3.1 Digital Biomarker Market: Region Footprint
        3.3.2 Digital Biomarker Market: Company Product Type Footprint
        3.3.3 Digital Biomarker Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Digital Biomarker Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Digital Biomarker Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Digital Biomarker Consumption Value Market Share by Application (2020-2025)
    5.2 Global Digital Biomarker Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Digital Biomarker Consumption Value by Type (2020-2031)
    6.2 North America Digital Biomarker Market Size by Application (2020-2031)
    6.3 North America Digital Biomarker Market Size by Country
        6.3.1 North America Digital Biomarker Consumption Value by Country (2020-2031)
        6.3.2 United States Digital Biomarker Market Size and Forecast (2020-2031)
        6.3.3 Canada Digital Biomarker Market Size and Forecast (2020-2031)
        6.3.4 Mexico Digital Biomarker Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Digital Biomarker Consumption Value by Type (2020-2031)
    7.2 Europe Digital Biomarker Consumption Value by Application (2020-2031)
    7.3 Europe Digital Biomarker Market Size by Country
        7.3.1 Europe Digital Biomarker Consumption Value by Country (2020-2031)
        7.3.2 Germany Digital Biomarker Market Size and Forecast (2020-2031)
        7.3.3 France Digital Biomarker Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Digital Biomarker Market Size and Forecast (2020-2031)
        7.3.5 Russia Digital Biomarker Market Size and Forecast (2020-2031)
        7.3.6 Italy Digital Biomarker Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Digital Biomarker Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Digital Biomarker Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Digital Biomarker Market Size by Region
        8.3.1 Asia-Pacific Digital Biomarker Consumption Value by Region (2020-2031)
        8.3.2 China Digital Biomarker Market Size and Forecast (2020-2031)
        8.3.3 Japan Digital Biomarker Market Size and Forecast (2020-2031)
        8.3.4 South Korea Digital Biomarker Market Size and Forecast (2020-2031)
        8.3.5 India Digital Biomarker Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Digital Biomarker Market Size and Forecast (2020-2031)
        8.3.7 Australia Digital Biomarker Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Digital Biomarker Consumption Value by Type (2020-2031)
    9.2 South America Digital Biomarker Consumption Value by Application (2020-2031)
    9.3 South America Digital Biomarker Market Size by Country
        9.3.1 South America Digital Biomarker Consumption Value by Country (2020-2031)
        9.3.2 Brazil Digital Biomarker Market Size and Forecast (2020-2031)
        9.3.3 Argentina Digital Biomarker Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Digital Biomarker Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Digital Biomarker Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Digital Biomarker Market Size by Country
        10.3.1 Middle East & Africa Digital Biomarker Consumption Value by Country (2020-2031)
        10.3.2 Turkey Digital Biomarker Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Digital Biomarker Market Size and Forecast (2020-2031)
        10.3.4 UAE Digital Biomarker Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Digital Biomarker Market Drivers
    11.2 Digital Biomarker Market Restraints
    11.3 Digital Biomarker Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Digital Biomarker Industry Chain
    12.2 Digital Biomarker Upstream Analysis
    12.3 Digital Biomarker Midstream Analysis
    12.4 Digital Biomarker Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Digital Biomarker Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Digital Biomarker Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Digital Biomarker Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Digital Biomarker Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. Philips Company Information, Head Office, and Major Competitors
 Table 6. Philips Major Business
 Table 7. Philips Digital Biomarker Product and Solutions
 Table 8. Philips Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. Philips Recent Developments and Future Plans
 Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
 Table 11. Johnson & Johnson Major Business
 Table 12. Johnson & Johnson Digital Biomarker Product and Solutions
 Table 13. Johnson & Johnson Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Johnson & Johnson Recent Developments and Future Plans
 Table 15. Pfizer Company Information, Head Office, and Major Competitors
 Table 16. Pfizer Major Business
 Table 17. Pfizer Digital Biomarker Product and Solutions
 Table 18. Pfizer Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. GE Healthcare Company Information, Head Office, and Major Competitors
 Table 20. GE Healthcare Major Business
 Table 21. GE Healthcare Digital Biomarker Product and Solutions
 Table 22. GE Healthcare Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. GE Healthcare Recent Developments and Future Plans
 Table 24. Novartis Company Information, Head Office, and Major Competitors
 Table 25. Novartis Major Business
 Table 26. Novartis Digital Biomarker Product and Solutions
 Table 27. Novartis Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. Novartis Recent Developments and Future Plans
 Table 29. Apple Company Information, Head Office, and Major Competitors
 Table 30. Apple Major Business
 Table 31. Apple Digital Biomarker Product and Solutions
 Table 32. Apple Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. Apple Recent Developments and Future Plans
 Table 34. Sanofi Company Information, Head Office, and Major Competitors
 Table 35. Sanofi Major Business
 Table 36. Sanofi Digital Biomarker Product and Solutions
 Table 37. Sanofi Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 38. Sanofi Recent Developments and Future Plans
 Table 39. GlaxoSmithKline Company Information, Head Office, and Major Competitors
 Table 40. GlaxoSmithKline Major Business
 Table 41. GlaxoSmithKline Digital Biomarker Product and Solutions
 Table 42. GlaxoSmithKline Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 43. GlaxoSmithKline Recent Developments and Future Plans
 Table 44. Bayer Company Information, Head Office, and Major Competitors
 Table 45. Bayer Major Business
 Table 46. Bayer Digital Biomarker Product and Solutions
 Table 47. Bayer Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 48. Bayer Recent Developments and Future Plans
 Table 49. Merck Company Information, Head Office, and Major Competitors
 Table 50. Merck Major Business
 Table 51. Merck Digital Biomarker Product and Solutions
 Table 52. Merck Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 53. Merck Recent Developments and Future Plans
 Table 54. Abbott Laboratories Company Information, Head Office, and Major Competitors
 Table 55. Abbott Laboratories Major Business
 Table 56. Abbott Laboratories Digital Biomarker Product and Solutions
 Table 57. Abbott Laboratories Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 58. Abbott Laboratories Recent Developments and Future Plans
 Table 59. Asahi Kasei Company Information, Head Office, and Major Competitors
 Table 60. Asahi Kasei Major Business
 Table 61. Asahi Kasei Digital Biomarker Product and Solutions
 Table 62. Asahi Kasei Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 63. Asahi Kasei Recent Developments and Future Plans
 Table 64. Biogen Company Information, Head Office, and Major Competitors
 Table 65. Biogen Major Business
 Table 66. Biogen Digital Biomarker Product and Solutions
 Table 67. Biogen Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 68. Biogen Recent Developments and Future Plans
 Table 69. Koneksa Health Company Information, Head Office, and Major Competitors
 Table 70. Koneksa Health Major Business
 Table 71. Koneksa Health Digital Biomarker Product and Solutions
 Table 72. Koneksa Health Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 73. Koneksa Health Recent Developments and Future Plans
 Table 74. Roche Company Information, Head Office, and Major Competitors
 Table 75. Roche Major Business
 Table 76. Roche Digital Biomarker Product and Solutions
 Table 77. Roche Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 78. Roche Recent Developments and Future Plans
 Table 79. Huma Therapeutics Company Information, Head Office, and Major Competitors
 Table 80. Huma Therapeutics Major Business
 Table 81. Huma Therapeutics Digital Biomarker Product and Solutions
 Table 82. Huma Therapeutics Digital Biomarker Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 83. Huma Therapeutics Recent Developments and Future Plans
 Table 84. Global Digital Biomarker Revenue (USD Million) by Players (2020-2025)
 Table 85. Global Digital Biomarker Revenue Share by Players (2020-2025)
 Table 86. Breakdown of Digital Biomarker by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 87. Market Position of Players in Digital Biomarker, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 88. Head Office of Key Digital Biomarker Players
 Table 89. Digital Biomarker Market: Company Product Type Footprint
 Table 90. Digital Biomarker Market: Company Product Application Footprint
 Table 91. Digital Biomarker New Market Entrants and Barriers to Market Entry
 Table 92. Digital Biomarker Mergers, Acquisition, Agreements, and Collaborations
 Table 93. Global Digital Biomarker Consumption Value (USD Million) by Type (2020-2025)
 Table 94. Global Digital Biomarker Consumption Value Share by Type (2020-2025)
 Table 95. Global Digital Biomarker Consumption Value Forecast by Type (2026-2031)
 Table 96. Global Digital Biomarker Consumption Value by Application (2020-2025)
 Table 97. Global Digital Biomarker Consumption Value Forecast by Application (2026-2031)
 Table 98. North America Digital Biomarker Consumption Value by Type (2020-2025) & (USD Million)
 Table 99. North America Digital Biomarker Consumption Value by Type (2026-2031) & (USD Million)
 Table 100. North America Digital Biomarker Consumption Value by Application (2020-2025) & (USD Million)
 Table 101. North America Digital Biomarker Consumption Value by Application (2026-2031) & (USD Million)
 Table 102. North America Digital Biomarker Consumption Value by Country (2020-2025) & (USD Million)
 Table 103. North America Digital Biomarker Consumption Value by Country (2026-2031) & (USD Million)
 Table 104. Europe Digital Biomarker Consumption Value by Type (2020-2025) & (USD Million)
 Table 105. Europe Digital Biomarker Consumption Value by Type (2026-2031) & (USD Million)
 Table 106. Europe Digital Biomarker Consumption Value by Application (2020-2025) & (USD Million)
 Table 107. Europe Digital Biomarker Consumption Value by Application (2026-2031) & (USD Million)
 Table 108. Europe Digital Biomarker Consumption Value by Country (2020-2025) & (USD Million)
 Table 109. Europe Digital Biomarker Consumption Value by Country (2026-2031) & (USD Million)
 Table 110. Asia-Pacific Digital Biomarker Consumption Value by Type (2020-2025) & (USD Million)
 Table 111. Asia-Pacific Digital Biomarker Consumption Value by Type (2026-2031) & (USD Million)
 Table 112. Asia-Pacific Digital Biomarker Consumption Value by Application (2020-2025) & (USD Million)
 Table 113. Asia-Pacific Digital Biomarker Consumption Value by Application (2026-2031) & (USD Million)
 Table 114. Asia-Pacific Digital Biomarker Consumption Value by Region (2020-2025) & (USD Million)
 Table 115. Asia-Pacific Digital Biomarker Consumption Value by Region (2026-2031) & (USD Million)
 Table 116. South America Digital Biomarker Consumption Value by Type (2020-2025) & (USD Million)
 Table 117. South America Digital Biomarker Consumption Value by Type (2026-2031) & (USD Million)
 Table 118. South America Digital Biomarker Consumption Value by Application (2020-2025) & (USD Million)
 Table 119. South America Digital Biomarker Consumption Value by Application (2026-2031) & (USD Million)
 Table 120. South America Digital Biomarker Consumption Value by Country (2020-2025) & (USD Million)
 Table 121. South America Digital Biomarker Consumption Value by Country (2026-2031) & (USD Million)
 Table 122. Middle East & Africa Digital Biomarker Consumption Value by Type (2020-2025) & (USD Million)
 Table 123. Middle East & Africa Digital Biomarker Consumption Value by Type (2026-2031) & (USD Million)
 Table 124. Middle East & Africa Digital Biomarker Consumption Value by Application (2020-2025) & (USD Million)
 Table 125. Middle East & Africa Digital Biomarker Consumption Value by Application (2026-2031) & (USD Million)
 Table 126. Middle East & Africa Digital Biomarker Consumption Value by Country (2020-2025) & (USD Million)
 Table 127. Middle East & Africa Digital Biomarker Consumption Value by Country (2026-2031) & (USD Million)
 Table 128. Global Key Players of Digital Biomarker Upstream (Raw Materials)
 Table 129. Global Digital Biomarker Typical Customers


List of Figures
 Figure 1. Digital Biomarker Picture
 Figure 2. Global Digital Biomarker Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Digital Biomarker Consumption Value Market Share by Type in 2024
 Figure 4. Passive Digital Biomarker
 Figure 5. Active Digital Biomarker
 Figure 6. Global Digital Biomarker Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 7. Digital Biomarker Consumption Value Market Share by Application in 2024
 Figure 8. Clinical Disease Picture
 Figure 9. Daily Health Picture
 Figure 10. Global Digital Biomarker Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 11. Global Digital Biomarker Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 12. Global Market Digital Biomarker Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 13. Global Digital Biomarker Consumption Value Market Share by Region (2020-2031)
 Figure 14. Global Digital Biomarker Consumption Value Market Share by Region in 2024
 Figure 15. North America Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 16. Europe Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 17. Asia-Pacific Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 18. South America Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 19. Middle East & Africa Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 20. Company Three Recent Developments and Future Plans
 Figure 21. Global Digital Biomarker Revenue Share by Players in 2024
 Figure 22. Digital Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 23. Market Share of Digital Biomarker by Player Revenue in 2024
 Figure 24. Top 3 Digital Biomarker Players Market Share in 2024
 Figure 25. Top 6 Digital Biomarker Players Market Share in 2024
 Figure 26. Global Digital Biomarker Consumption Value Share by Type (2020-2025)
 Figure 27. Global Digital Biomarker Market Share Forecast by Type (2026-2031)
 Figure 28. Global Digital Biomarker Consumption Value Share by Application (2020-2025)
 Figure 29. Global Digital Biomarker Market Share Forecast by Application (2026-2031)
 Figure 30. North America Digital Biomarker Consumption Value Market Share by Type (2020-2031)
 Figure 31. North America Digital Biomarker Consumption Value Market Share by Application (2020-2031)
 Figure 32. North America Digital Biomarker Consumption Value Market Share by Country (2020-2031)
 Figure 33. United States Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 34. Canada Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 35. Mexico Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 36. Europe Digital Biomarker Consumption Value Market Share by Type (2020-2031)
 Figure 37. Europe Digital Biomarker Consumption Value Market Share by Application (2020-2031)
 Figure 38. Europe Digital Biomarker Consumption Value Market Share by Country (2020-2031)
 Figure 39. Germany Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 40. France Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 41. United Kingdom Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 42. Russia Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 43. Italy Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 44. Asia-Pacific Digital Biomarker Consumption Value Market Share by Type (2020-2031)
 Figure 45. Asia-Pacific Digital Biomarker Consumption Value Market Share by Application (2020-2031)
 Figure 46. Asia-Pacific Digital Biomarker Consumption Value Market Share by Region (2020-2031)
 Figure 47. China Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 48. Japan Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 49. South Korea Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 50. India Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 51. Southeast Asia Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 52. Australia Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 53. South America Digital Biomarker Consumption Value Market Share by Type (2020-2031)
 Figure 54. South America Digital Biomarker Consumption Value Market Share by Application (2020-2031)
 Figure 55. South America Digital Biomarker Consumption Value Market Share by Country (2020-2031)
 Figure 56. Brazil Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 57. Argentina Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 58. Middle East & Africa Digital Biomarker Consumption Value Market Share by Type (2020-2031)
 Figure 59. Middle East & Africa Digital Biomarker Consumption Value Market Share by Application (2020-2031)
 Figure 60. Middle East & Africa Digital Biomarker Consumption Value Market Share by Country (2020-2031)
 Figure 61. Turkey Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 62. Saudi Arabia Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 63. UAE Digital Biomarker Consumption Value (2020-2031) & (USD Million)
 Figure 64. Digital Biomarker Market Drivers
 Figure 65. Digital Biomarker Market Restraints
 Figure 66. Digital Biomarker Market Trends
 Figure 67. Porters Five Forces Analysis
 Figure 68. Digital Biomarker Industrial Chain
 Figure 69. Methodology
 Figure 70. Research Process and Data Source

Companies Mentioned

Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Apple
Sanofi
GlaxoSmithKline
Bayer
Merck
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics